NAZALONE

Amphastar Pharmaceuticals, Inc.

Application Filed: 2015-09-04

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	86748379
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Mark Harrison
Attorney Docket Number	120780-39021
Law Office Assigned	L40
Employee Name	RAPPAPORT, SETH A

Timeline

2015-09-04	Application Filed
2016-02-09	Published for Opposition
2016-04-05	Location: INTENT TO USE SECTION
2016-11-07	Abandon
2016-11-07	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Amphastar Pharmaceuticals, Inc.
Address	11570 Sixth Street Rancho Cucamonga DE 91730
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

MARK HARRISON
Venable Llp
PO Box 34385
Washington, DC 20043-4385

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics

Type Code

Type

GS0051

Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2015-09-08	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2015-09-09	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2015-09-24	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2015-10-01	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2015-10-01	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2015-10-01	6 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2015-10-15	7 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2015-10-15	8 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2015-10-15	9 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2015-10-16	10 CNSA P:
ASSIGNED TO LIE	2015-12-29	11 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2016-01-05	12 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2016-01-20	13 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2016-02-09	14 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2016-02-09	15 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2016-04-05	16 NOAM E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2016-11-07	17 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2016-11-07	18 MAB6 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
NAZALONE 86748379 not registered Dead/Abandoned	Amphastar Pharmaceuticals, Inc. 2015-09-04
NAZALONE 86748246 not registered Dead/Abandoned	Amphastar Pharmaceuticals, Inc. 2015-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.